1315 Capital II, L.P. has filed 4 insider transactions across 1 company since October 2024.
Most recent transaction: a transaction of 9405941 shares of INTERPACE BIOSCIENCES, INC. ($IDXG) on January 20, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 20, 2026 | INTERPACE BIOSCIENCES, INC. | $IDXG | 1315 Capital II, L.P. | TenPercentOwner | C | Common Stock | 9405941 | $2.02 | 9,405,941.0000 | 27,695,000 | 9999.99% | 33.96% |
| Jan. 20, 2026 | INTERPACE BIOSCIENCES, INC. | $IDXG | 1315 Capital II, L.P. | TenPercentOwner | C | Series C Convertible Preferred Stock | 19000 | $0.00 | 0.0000 | 27,695,000 | 100.00% | 0.07% |
| Oct. 11, 2024 | INTERPACE BIOSCIENCES, INC. | $IDXG | 1315 Capital II, L.P. | TenPercentOwner | D | Series B Convertible Preferred Stock | 19000 | $0.00 | 0.0000 | 4,423,000 | 0.00% | 0.43% |
| Oct. 11, 2024 | INTERPACE BIOSCIENCES, INC. | $IDXG | 1315 Capital II, L.P. | TenPercentOwner | A | Series C Convertible Preferred Stock | 19000 | $0.00 | 19,000.0000 | 4,423,000 | 9999.99% | 0.43% |